Premium
Letter: biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease
Author(s) -
Savarino E.,
Bodini G.,
Savarino V.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13605
Subject(s) - medicine , infliximab , crohn's disease , disease , natural history , placebo , odds ratio , smoking history , odds , smoking cessation , randomized controlled trial , adverse effect , surgery , alternative medicine , logistic regression , pathology